Oil-Free Compressor
Oil-Free Compressor market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More
1 Study Coverage 1.1 Liposomes Drug Delivery Product Introduction 1.2 Market by Type 1.2.1 Global Liposomes Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Liposomal Doxorubicin 1.2.3 Liposomal Amphoteracin B 1.2.4 Liposomal Paclitaxel 1.2.5 Others 1.3 Market by Application 1.3.1 Global Liposomes Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Fungal Infection Therapy 1.3.3 Cancer & Tumor Therapy 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Liposomes Drug Delivery Sales Estimates and Forecasts 2017-2028 2.2 Global Liposomes Drug Delivery Revenue Estimates and Forecasts 2017-2028 2.3 Global Liposomes Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Liposomes Drug Delivery Sales by Region 2.4.1 Global Liposomes Drug Delivery Sales by Region (2017-2022) 2.4.2 Global Sales Liposomes Drug Delivery by Region (2023-2028) 2.5 Global Liposomes Drug Delivery Revenue by Region 2.5.1 Global Liposomes Drug Delivery Revenue by Region (2017-2022) 2.5.2 Global Liposomes Drug Delivery Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Liposomes Drug Delivery Sales by Manufacturers 3.1.1 Global Top Liposomes Drug Delivery Manufacturers by Sales (2017-2022) 3.1.2 Global Liposomes Drug Delivery Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Liposomes Drug Delivery in 2021 3.2 Global Liposomes Drug Delivery Revenue by Manufacturers 3.2.1 Global Liposomes Drug Delivery Revenue by Manufacturers (2017-2022) 3.2.2 Global Liposomes Drug Delivery Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Liposomes Drug Delivery Revenue in 2021 3.3 Global Liposomes Drug Delivery Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Liposomes Drug Delivery Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Liposomes Drug Delivery Sales by Type 4.1.1 Global Liposomes Drug Delivery Historical Sales by Type (2017-2022) 4.1.2 Global Liposomes Drug Delivery Forecasted Sales by Type (2023-2028) 4.1.3 Global Liposomes Drug Delivery Sales Market Share by Type (2017-2028) 4.2 Global Liposomes Drug Delivery Revenue by Type 4.2.1 Global Liposomes Drug Delivery Historical Revenue by Type (2017-2022) 4.2.2 Global Liposomes Drug Delivery Forecasted Revenue by Type (2023-2028) 4.2.3 Global Liposomes Drug Delivery Revenue Market Share by Type (2017-2028) 4.3 Global Liposomes Drug Delivery Price by Type 4.3.1 Global Liposomes Drug Delivery Price by Type (2017-2022) 4.3.2 Global Liposomes Drug Delivery Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Liposomes Drug Delivery Sales by Application 5.1.1 Global Liposomes Drug Delivery Historical Sales by Application (2017-2022) 5.1.2 Global Liposomes Drug Delivery Forecasted Sales by Application (2023-2028) 5.1.3 Global Liposomes Drug Delivery Sales Market Share by Application (2017-2028) 5.2 Global Liposomes Drug Delivery Revenue by Application 5.2.1 Global Liposomes Drug Delivery Historical Revenue by Application (2017-2022) 5.2.2 Global Liposomes Drug Delivery Forecasted Revenue by Application (2023-2028) 5.2.3 Global Liposomes Drug Delivery Revenue Market Share by Application (2017-2028) 5.3 Global Liposomes Drug Delivery Price by Application 5.3.1 Global Liposomes Drug Delivery Price by Application (2017-2022) 5.3.2 Global Liposomes Drug Delivery Price Forecast by Application (2023-2028) 6 North America 6.1 North America Liposomes Drug Delivery Market Size by Type 6.1.1 North America Liposomes Drug Delivery Sales by Type (2017-2028) 6.1.2 North America Liposomes Drug Delivery Revenue by Type (2017-2028) 6.2 North America Liposomes Drug Delivery Market Size by Application 6.2.1 North America Liposomes Drug Delivery Sales by Application (2017-2028) 6.2.2 North America Liposomes Drug Delivery Revenue by Application (2017-2028) 6.3 North America Liposomes Drug Delivery Market Size by Country 6.3.1 North America Liposomes Drug Delivery Sales by Country (2017-2028) 6.3.2 North America Liposomes Drug Delivery Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Liposomes Drug Delivery Market Size by Type 7.1.1 Europe Liposomes Drug Delivery Sales by Type (2017-2028) 7.1.2 Europe Liposomes Drug Delivery Revenue by Type (2017-2028) 7.2 Europe Liposomes Drug Delivery Market Size by Application 7.2.1 Europe Liposomes Drug Delivery Sales by Application (2017-2028) 7.2.2 Europe Liposomes Drug Delivery Revenue by Application (2017-2028) 7.3 Europe Liposomes Drug Delivery Market Size by Country 7.3.1 Europe Liposomes Drug Delivery Sales by Country (2017-2028) 7.3.2 Europe Liposomes Drug Delivery Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Liposomes Drug Delivery Market Size by Type 8.1.1 Asia Pacific Liposomes Drug Delivery Sales by Type (2017-2028) 8.1.2 Asia Pacific Liposomes Drug Delivery Revenue by Type (2017-2028) 8.2 Asia Pacific Liposomes Drug Delivery Market Size by Application 8.2.1 Asia Pacific Liposomes Drug Delivery Sales by Application (2017-2028) 8.2.2 Asia Pacific Liposomes Drug Delivery Revenue by Application (2017-2028) 8.3 Asia Pacific Liposomes Drug Delivery Market Size by Region 8.3.1 Asia Pacific Liposomes Drug Delivery Sales by Region (2017-2028) 8.3.2 Asia Pacific Liposomes Drug Delivery Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 China Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 9 Latin America 9.1 Latin America Liposomes Drug Delivery Market Size by Type 9.1.1 Latin America Liposomes Drug Delivery Sales by Type (2017-2028) 9.1.2 Latin America Liposomes Drug Delivery Revenue by Type (2017-2028) 9.2 Latin America Liposomes Drug Delivery Market Size by Application 9.2.1 Latin America Liposomes Drug Delivery Sales by Application (2017-2028) 9.2.2 Latin America Liposomes Drug Delivery Revenue by Application (2017-2028) 9.3 Latin America Liposomes Drug Delivery Market Size by Country 9.3.1 Latin America Liposomes Drug Delivery Sales by Country (2017-2028) 9.3.2 Latin America Liposomes Drug Delivery Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Liposomes Drug Delivery Market Size by Type 10.1.1 Middle East and Africa Liposomes Drug Delivery Sales by Type (2017-2028) 10.1.2 Middle East and Africa Liposomes Drug Delivery Revenue by Type (2017-2028) 10.2 Middle East and Africa Liposomes Drug Delivery Market Size by Application 10.2.1 Middle East and Africa Liposomes Drug Delivery Sales by Application (2017-2028) 10.2.2 Middle East and Africa Liposomes Drug Delivery Revenue by Application (2017-2028) 10.3 Middle East and Africa Liposomes Drug Delivery Market Size by Country 10.3.1 Middle East and Africa Liposomes Drug Delivery Sales by Country (2017-2028) 10.3.2 Middle East and Africa Liposomes Drug Delivery Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Johnson & Johnson 11.1.1 Johnson & Johnson Corporation Information 11.1.2 Johnson & Johnson Overview 11.1.3 Johnson & Johnson Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Johnson & Johnson Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Johnson & Johnson Recent Developments 11.2 Gilead Sciences 11.2.1 Gilead Sciences Corporation Information 11.2.2 Gilead Sciences Overview 11.2.3 Gilead Sciences Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Gilead Sciences Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Gilead Sciences Recent Developments 11.3 Pacira 11.3.1 Pacira Corporation Information 11.3.2 Pacira Overview 11.3.3 Pacira Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Pacira Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Pacira Recent Developments 11.4 Sun Pharmaceutical 11.4.1 Sun Pharmaceutical Corporation Information 11.4.2 Sun Pharmaceutical Overview 11.4.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Sun Pharmaceutical Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Sun Pharmaceutical Recent Developments 11.5 Luye Pharma 11.5.1 Luye Pharma Corporation Information 11.5.2 Luye Pharma Overview 11.5.3 Luye Pharma Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Luye Pharma Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Luye Pharma Recent Developments 11.6 Sigma-Tau Group 11.6.1 Sigma-Tau Group Corporation Information 11.6.2 Sigma-Tau Group Overview 11.6.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Sigma-Tau Group Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Sigma-Tau Group Recent Developments 11.7 Fudan-Zhangjiang 11.7.1 Fudan-Zhangjiang Corporation Information 11.7.2 Fudan-Zhangjiang Overview 11.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Fudan-Zhangjiang Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Fudan-Zhangjiang Recent Developments 11.8 Teva Pharmaceutical 11.8.1 Teva Pharmaceutical Corporation Information 11.8.2 Teva Pharmaceutical Overview 11.8.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Teva Pharmaceutical Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Teva Pharmaceutical Recent Developments 11.9 CSPC 11.9.1 CSPC Corporation Information 11.9.2 CSPC Overview 11.9.3 CSPC Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 CSPC Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 CSPC Recent Developments 11.10 Novartis 11.10.1 Novartis Corporation Information 11.10.2 Novartis Overview 11.10.3 Novartis Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Novartis Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Novartis Recent Developments 11.11 Kingond Pharm 11.11.1 Kingond Pharm Corporation Information 11.11.2 Kingond Pharm Overview 11.11.3 Kingond Pharm Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 Kingond Pharm Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 Kingond Pharm Recent Developments 11.12 Spectrum Pharmaceuticals 11.12.1 Spectrum Pharmaceuticals Corporation Information 11.12.2 Spectrum Pharmaceuticals Overview 11.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Spectrum Pharmaceuticals Recent Developments 11.13 Shanghai New Asia 11.13.1 Shanghai New Asia Corporation Information 11.13.2 Shanghai New Asia Overview 11.13.3 Shanghai New Asia Liposomes Drug Delivery Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 Shanghai New Asia Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 Shanghai New Asia Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Liposomes Drug Delivery Industry Chain Analysis 12.2 Liposomes Drug Delivery Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Liposomes Drug Delivery Production Mode & Process 12.4 Liposomes Drug Delivery Sales and Marketing 12.4.1 Liposomes Drug Delivery Sales Channels 12.4.2 Liposomes Drug Delivery Distributors 12.5 Liposomes Drug Delivery Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Liposomes Drug Delivery Industry Trends 13.2 Liposomes Drug Delivery Market Drivers 13.3 Liposomes Drug Delivery Market Challenges 13.4 Liposomes Drug Delivery Market Restraints 14 Key Findings in The Global Liposomes Drug Delivery Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
List of Tables Table 1. Global Liposomes Drug Delivery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Liposomal Doxorubicin Table 3. Major Manufacturers of Liposomal Amphoteracin B Table 4. Major Manufacturers of Liposomal Paclitaxel Table 5. Major Manufacturers of Others Table 6. Global Liposomes Drug Delivery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 7. Global Liposomes Drug Delivery Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million) Table 8. Global Liposomes Drug Delivery Sales by Region (2017-2022) & (K Vials) Table 9. Global Liposomes Drug Delivery Sales Market Share by Region (2017-2022) Table 10. Global Liposomes Drug Delivery Sales by Region (2023-2028) & (K Vials) Table 11. Global Liposomes Drug Delivery Sales Market Share by Region (2023-2028) Table 12. Global Liposomes Drug Delivery Revenue by Region (2017-2022) & (US$ Million) Table 13. Global Liposomes Drug Delivery Revenue Market Share by Region (2017-2022) Table 14. Global Liposomes Drug Delivery Revenue by Region (2023-2028) & (US$ Million) Table 15. Global Liposomes Drug Delivery Revenue Market Share by Region (2023-2028) Table 16. Global Liposomes Drug Delivery Sales by Manufacturers (2017-2022) & (K Vials) Table 17. Global Liposomes Drug Delivery Sales Share by Manufacturers (2017-2022) Table 18. Global Liposomes Drug Delivery Revenue by Manufacturers (2017-2022) & (US$ Million) Table 19. Global Liposomes Drug Delivery Revenue Share by Manufacturers (2017-2022) Table 20. Liposomes Drug Delivery Price by Manufacturers (2017-2022) &(USD/Vial) Table 21. Global Liposomes Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) Table 22. Global Liposomes Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomes Drug Delivery as of 2021) Table 23. Liposomes Drug Delivery Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Liposomes Drug Delivery Product Offered Table 25. Date of Manufacturers Enter into Liposomes Drug Delivery Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Liposomes Drug Delivery Sales by Type (2017-2022) & (K Vials) Table 28. Global Liposomes Drug Delivery Sales by Type (2023-2028) & (K Vials) Table 29. Global Liposomes Drug Delivery Sales Share by Type (2017-2022) Table 30. Global Liposomes Drug Delivery Sales Share by Type (2023-2028) Table 31. Global Liposomes Drug Delivery Revenue by Type (2017-2022) & (US$ Million) Table 32. Global Liposomes Drug Delivery Revenue by Type (2023-2028) & (US$ Million) Table 33. Global Liposomes Drug Delivery Revenue Share by Type (2017-2022) Table 34. Global Liposomes Drug Delivery Revenue Share by Type (2023-2028) Table 35. Liposomes Drug Delivery Price by Type (2017-2022) & (USD/Vial) Table 36. Global Liposomes Drug Delivery Price Forecast by Type (2023-2028) & (USD/Vial) Table 37. Global Liposomes Drug Delivery Sales by Application (2017-2022) & (K Vials) Table 38. Global Liposomes Drug Delivery Sales by Application (2023-2028) & (K Vials) Table 39. Global Liposomes Drug Delivery Sales Share by Application (2017-2022) Table 40. Global Liposomes Drug Delivery Sales Share by Application (2023-2028) Table 41. Global Liposomes Drug Delivery Revenue by Application (2017-2022) & (US$ Million) Table 42. Global Liposomes Drug Delivery Revenue by Application (2023-2028) & (US$ Million) Table 43. Global Liposomes Drug Delivery Revenue Share by Application (2017-2022) Table 44. Global Liposomes Drug Delivery Revenue Share by Application (2023-2028) Table 45. Liposomes Drug Delivery Price by Application (2017-2022) & (USD/Vial) Table 46. Global Liposomes Drug Delivery Price Forecast by Application (2023-2028) & (USD/Vial) Table 47. North America Liposomes Drug Delivery Sales by Type (2017-2022) & (K Vials) Table 48. North America Liposomes Drug Delivery Sales by Type (2023-2028) & (K Vials) Table 49. North America Liposomes Drug Delivery Revenue by Type (2017-2022) & (US$ Million) Table 50. North America Liposomes Drug Delivery Revenue by Type (2023-2028) & (US$ Million) Table 51. North America Liposomes Drug Delivery Sales by Application (2017-2022) & (K Vials) Table 52. North America Liposomes Drug Delivery Sales by Application (2023-2028) & (K Vials) Table 53. North America Liposomes Drug Delivery Revenue by Application (2017-2022) & (US$ Million) Table 54. North America Liposomes Drug Delivery Revenue by Application (2023-2028) & (US$ Million) Table 55. North America Liposomes Drug Delivery Sales by Country (2017-2022) & (K Vials) Table 56. North America Liposomes Drug Delivery Sales by Country (2023-2028) & (K Vials) Table 57. North America Liposomes Drug Delivery Revenue by Country (2017-2022) & (US$ Million) Table 58. North America Liposomes Drug Delivery Revenue by Country (2023-2028) & (US$ Million) Table 59. Europe Liposomes Drug Delivery Sales by Type (2017-2022) & (K Vials) Table 60. Europe Liposomes Drug Delivery Sales by Type (2023-2028) & (K Vials) Table 61. Europe Liposomes Drug Delivery Revenue by Type (2017-2022) & (US$ Million) Table 62. Europe Liposomes Drug Delivery Revenue by Type (2023-2028) & (US$ Million) Table 63. Europe Liposomes Drug Delivery Sales by Application (2017-2022) & (K Vials) Table 64. Europe Liposomes Drug Delivery Sales by Application (2023-2028) & (K Vials) Table 65. Europe Liposomes Drug Delivery Revenue by Application (2017-2022) & (US$ Million) Table 66. Europe Liposomes Drug Delivery Revenue by Application (2023-2028) & (US$ Million) Table 67. Europe Liposomes Drug Delivery Sales by Country (2017-2022) & (K Vials) Table 68. Europe Liposomes Drug Delivery Sales by Country (2023-2028) & (K Vials) Table 69. Europe Liposomes Drug Delivery Revenue by Country (2017-2022) & (US$ Million) Table 70. Europe Liposomes Drug Delivery Revenue by Country (2023-2028) & (US$ Million) Table 71. Asia Pacific Liposomes Drug Delivery Sales by Type (2017-2022) & (K Vials) Table 72. Asia Pacific Liposomes Drug Delivery Sales by Type (2023-2028) & (K Vials) Table 73. Asia Pacific Liposomes Drug Delivery Revenue by Type (2017-2022) & (US$ Million) Table 74. Asia Pacific Liposomes Drug Delivery Revenue by Type (2023-2028) & (US$ Million) Table 75. Asia Pacific Liposomes Drug Delivery Sales by Application (2017-2022) & (K Vials) Table 76. Asia Pacific Liposomes Drug Delivery Sales by Application (2023-2028) & (K Vials) Table 77. Asia Pacific Liposomes Drug Delivery Revenue by Application (2017-2022) & (US$ Million) Table 78. Asia Pacific Liposomes Drug Delivery Revenue by Application (2023-2028) & (US$ Million) Table 79. Asia Pacific Liposomes Drug Delivery Sales by Region (2017-2022) & (K Vials) Table 80. Asia Pacific Liposomes Drug Delivery Sales by Region (2023-2028) & (K Vials) Table 81. Asia Pacific Liposomes Drug Delivery Revenue by Region (2017-2022) & (US$ Million) Table 82. Asia Pacific Liposomes Drug Delivery Revenue by Region (2023-2028) & (US$ Million) Table 83. Latin America Liposomes Drug Delivery Sales by Type (2017-2022) & (K Vials) Table 84. Latin America Liposomes Drug Delivery Sales by Type (2023-2028) & (K Vials) Table 85. Latin America Liposomes Drug Delivery Revenue by Type (2017-2022) & (US$ Million) Table 86. Latin America Liposomes Drug Delivery Revenue by Type (2023-2028) & (US$ Million) Table 87. Latin America Liposomes Drug Delivery Sales by Application (2017-2022) & (K Vials) Table 88. Latin America Liposomes Drug Delivery Sales by Application (2023-2028) & (K Vials) Table 89. Latin America Liposomes Drug Delivery Revenue by Application (2017-2022) & (US$ Million) Table 90. Latin America Liposomes Drug Delivery Revenue by Application (2023-2028) & (US$ Million) Table 91. Latin America Liposomes Drug Delivery Sales by Country (2017-2022) & (K Vials) Table 92. Latin America Liposomes Drug Delivery Sales by Country (2023-2028) & (K Vials) Table 93. Latin America Liposomes Drug Delivery Revenue by Country (2017-2022) & (US$ Million) Table 94. Latin America Liposomes Drug Delivery Revenue by Country (2023-2028) & (US$ Million) Table 95. Middle East and Africa Liposomes Drug Delivery Sales by Type (2017-2022) & (K Vials) Table 96. Middle East and Africa Liposomes Drug Delivery Sales by Type (2023-2028) & (K Vials) Table 97. Middle East and Africa Liposomes Drug Delivery Revenue by Type (2017-2022) & (US$ Million) Table 98. Middle East and Africa Liposomes Drug Delivery Revenue by Type (2023-2028) & (US$ Million) Table 99. Middle East and Africa Liposomes Drug Delivery Sales by Application (2017-2022) & (K Vials) Table 100. Middle East and Africa Liposomes Drug Delivery Sales by Application (2023-2028) & (K Vials) Table 101. Middle East and Africa Liposomes Drug Delivery Revenue by Application (2017-2022) & (US$ Million) Table 102. Middle East and Africa Liposomes Drug Delivery Revenue by Application (2023-2028) & (US$ Million) Table 103. Middle East and Africa Liposomes Drug Delivery Sales by Country (2017-2022) & (K Vials) Table 104. Middle East and Africa Liposomes Drug Delivery Sales by Country (2023-2028) & (K Vials) Table 105. Middle East and Africa Liposomes Drug Delivery Revenue by Country (2017-2022) & (US$ Million) Table 106. Middle East and Africa Liposomes Drug Delivery Revenue by Country (2023-2028) & (US$ Million) Table 107. Johnson & Johnson Corporation Information Table 108. Johnson & Johnson Description and Major Businesses Table 109. Johnson & Johnson Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 110. Johnson & Johnson Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications Table 111. Johnson & Johnson Recent Developments Table 112. Gilead Sciences Corporation Information Table 113. Gilead Sciences Description and Major Businesses Table 114. Gilead Sciences Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 115. Gilead Sciences Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications Table 116. Gilead Sciences Recent Developments Table 117. Pacira Corporation Information Table 118. Pacira Description and Major Businesses Table 119. Pacira Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 120. Pacira Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications Table 121. Pacira Recent Developments Table 122. Sun Pharmaceutical Corporation Information Table 123. Sun Pharmaceutical Description and Major Businesses Table 124. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 125. Sun Pharmaceutical Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications Table 126. Sun Pharmaceutical Recent Developments Table 127. Luye Pharma Corporation Information Table 128. Luye Pharma Description and Major Businesses Table 129. Luye Pharma Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 130. Luye Pharma Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications Table 131. Luye Pharma Recent Developments Table 132. Sigma-Tau Group Corporation Information Table 133. Sigma-Tau Group Description and Major Businesses Table 134. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 135. Sigma-Tau Group Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications Table 136. Sigma-Tau Group Recent Developments Table 137. Fudan-Zhangjiang Corporation Information Table 138. Fudan-Zhangjiang Description and Major Businesses Table 139. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 140. Fudan-Zhangjiang Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications Table 141. Fudan-Zhangjiang Recent Developments Table 142. Teva Pharmaceutical Corporation Information Table 143. Teva Pharmaceutical Description and Major Businesses Table 144. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 145. Teva Pharmaceutical Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications Table 146. Teva Pharmaceutical Recent Developments Table 147. CSPC Corporation Information Table 148. CSPC Description and Major Businesses Table 149. CSPC Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 150. CSPC Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications Table 151. CSPC Recent Developments Table 152. Novartis Corporation Information Table 153. Novartis Description and Major Businesses Table 154. Novartis Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 155. Novartis Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications Table 156. Novartis Recent Developments Table 157. Kingond Pharm Corporation Information Table 158. Kingond Pharm Description and Major Businesses Table 159. Kingond Pharm Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 160. Kingond Pharm Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications Table 161. Kingond Pharm Recent Developments Table 162. Spectrum Pharmaceuticals Corporation Information Table 163. Spectrum Pharmaceuticals Description and Major Businesses Table 164. Spectrum Pharmaceuticals Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 165. Spectrum Pharmaceuticals Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications Table 166. Spectrum Pharmaceuticals Recent Developments Table 167. Shanghai New Asia Corporation Information Table 168. Shanghai New Asia Description and Major Businesses Table 169. Shanghai New Asia Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2017-2022) Table 170. Shanghai New Asia Liposomes Drug Delivery Product Model Numbers, Pictures, Descriptions and Specifications Table 171. Shanghai New Asia Recent Developments Table 172. Key Raw Materials Lists Table 173. Raw Materials Key Suppliers Lists Table 174. Liposomes Drug Delivery Distributors List Table 175. Liposomes Drug Delivery Customers List Table 176. Liposomes Drug Delivery Market Trends Table 177. Liposomes Drug Delivery Market Drivers Table 178. Liposomes Drug Delivery Market Challenges Table 179. Liposomes Drug Delivery Market Restraints Table 180. Research Programs/Design for This Report Table 181. Key Data Information from Secondary Sources Table 182. Key Data Information from Primary Sources List of Figures Figure 1. Liposomes Drug Delivery Product Picture Figure 3. Global Liposomes Drug Delivery Market Share by Type in 2021 & 2028 Figure 3. Liposomal Doxorubicin Product Picture Figure 4. Liposomal Amphoteracin B Product Picture Figure 5. Liposomal Paclitaxel Product Picture Figure 6. Others Product Picture Figure 7. Global Liposomes Drug Delivery Market Share by Application in 2021 & 2028 Figure 8. Fungal Infection Therapy Figure 9. Cancer & Tumor Therapy Figure 10. Others Figure 11. Liposomes Drug Delivery Report Years Considered Figure 12. Global Liposomes Drug Delivery Sales 2017-2028 (K Vials) Figure 13. Global Liposomes Drug Delivery Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Liposomes Drug Delivery Revenue 2017-2028 (US$ Million) Figure 15. Global Liposomes Drug Delivery Revenue Market Share by Region in Percentage: 2021 Versus 2028 Figure 16. Global Liposomes Drug Delivery Sales Market Share by Region (2017-2022) Figure 17. Global Liposomes Drug Delivery Sales Market Share by Region (2023-2028) Figure 18. North America Liposomes Drug Delivery Sales YoY (2017-2028) & (K Vials) Figure 19. North America Liposomes Drug Delivery Revenue YoY (2017-2028) & (US$ Million) Figure 20. Europe Liposomes Drug Delivery Sales YoY (2017-2028) & (K Vials) Figure 21. Europe Liposomes Drug Delivery Revenue YoY (2017-2028) & (US$ Million) Figure 22. Asia-Pacific Liposomes Drug Delivery Sales YoY (2017-2028) & (K Vials) Figure 23. Asia-Pacific Liposomes Drug Delivery Revenue YoY (2017-2028) & (US$ Million) Figure 24. Latin America Liposomes Drug Delivery Sales YoY (2017-2028) & (K Vials) Figure 25. Latin America Liposomes Drug Delivery Revenue YoY (2017-2028) & (US$ Million) Figure 26. Middle East & Africa Liposomes Drug Delivery Sales YoY (2017-2028) & (K Vials) Figure 27. Middle East & Africa Liposomes Drug Delivery Revenue YoY (2017-2028) & (US$ Million) Figure 28. The Liposomes Drug Delivery Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021 Figure 29. The Top 5 and 10 Largest Manufacturers of Liposomes Drug Delivery in the World: Market Share by Liposomes Drug Delivery Revenue in 2021 Figure 30. Global Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021 Figure 31. Global Liposomes Drug Delivery Sales Market Share by Type (2017-2028) Figure 32. Global Liposomes Drug Delivery Revenue Market Share by Type (2017-2028) Figure 33. Global Liposomes Drug Delivery Sales Market Share by Application (2017-2028) Figure 34. Global Liposomes Drug Delivery Revenue Market Share by Application (2017-2028) Figure 35. North America Liposomes Drug Delivery Sales Market Share by Type (2017-2028) Figure 36. North America Liposomes Drug Delivery Revenue Market Share by Type (2017-2028) Figure 37. North America Liposomes Drug Delivery Sales Market Share by Application (2017-2028) Figure 38. North America Liposomes Drug Delivery Revenue Market Share by Application (2017-2028) Figure 39. North America Liposomes Drug Delivery Sales Share by Country (2017-2028) Figure 40. North America Liposomes Drug Delivery Revenue Share by Country (2017-2028) Figure 41. U.S. Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 42. Canada Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 43. Europe Liposomes Drug Delivery Sales Market Share by Type (2017-2028) Figure 44. Europe Liposomes Drug Delivery Revenue Market Share by Type (2017-2028) Figure 45. Europe Liposomes Drug Delivery Sales Market Share by Application (2017-2028) Figure 46. Europe Liposomes Drug Delivery Revenue Market Share by Application (2017-2028) Figure 47. Europe Liposomes Drug Delivery Sales Share by Country (2017-2028) Figure 48. Europe Liposomes Drug Delivery Revenue Share by Country (2017-2028) Figure 49. Germany Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 50. France Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 51. U.K. Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 52. Italy Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 53. Russia Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 54. Asia Pacific Liposomes Drug Delivery Sales Market Share by Type (2017-2028) Figure 55. Asia Pacific Liposomes Drug Delivery Revenue Market Share by Type (2017-2028) Figure 56. Asia Pacific Liposomes Drug Delivery Sales Market Share by Application (2017-2028) Figure 57. Asia Pacific Liposomes Drug Delivery Revenue Market Share by Application (2017-2028) Figure 58. Asia Pacific Liposomes Drug Delivery Sales Share by Region (2017-2028) Figure 59. Asia Pacific Liposomes Drug Delivery Revenue Share by Region (2017-2028) Figure 60. China Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 61. Japan Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 62. South Korea Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 63. India Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 64. Australia Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 65. China Taiwan Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 66. Indonesia Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 67. Thailand Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 68. Malaysia Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 69. Latin America Liposomes Drug Delivery Sales Market Share by Type (2017-2028) Figure 70. Latin America Liposomes Drug Delivery Revenue Market Share by Type (2017-2028) Figure 71. Latin America Liposomes Drug Delivery Sales Market Share by Application (2017-2028) Figure 72. Latin America Liposomes Drug Delivery Revenue Market Share by Application (2017-2028) Figure 73. Latin America Liposomes Drug Delivery Sales Share by Country (2017-2028) Figure 74. Latin America Liposomes Drug Delivery Revenue Share by Country (2017-2028) Figure 75. Mexico Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 76. Brazil Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 77. Argentina Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 78. Middle East and Africa Liposomes Drug Delivery Sales Market Share by Type (2017-2028) Figure 79. Middle East and Africa Liposomes Drug Delivery Revenue Market Share by Type (2017-2028) Figure 80. Middle East and Africa Liposomes Drug Delivery Sales Market Share by Application (2017-2028) Figure 81. Middle East and Africa Liposomes Drug Delivery Revenue Market Share by Application (2017-2028) Figure 82. Middle East and Africa Liposomes Drug Delivery Sales Share by Country (2017-2028) Figure 83. Middle East and Africa Liposomes Drug Delivery Revenue Share by Country (2017-2028) Figure 84. Turkey Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 85. Saudi Arabia Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 86. UAE Liposomes Drug Delivery Revenue (2017-2028) & (US$ Million) Figure 87. Liposomes Drug Delivery Value Chain Figure 88. Liposomes Drug Delivery Production Process Figure 89. Channels of Distribution Figure 90. Distributors Profiles Figure 91. Bottom-up and Top-down Approaches for This Report Figure 92. Data Triangulation Figure 93. Key Executives Interviewed
Johnson & Johnson Gilead Sciences Pacira Sun Pharmaceutical Luye Pharma Sigma-Tau Group Fudan-Zhangjiang Teva Pharmaceutical CSPC Novartis Kingond Pharm Spectrum Pharmaceuticals Shanghai New Asia
Oil-Free Compressor market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More
Plastic Bucket market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More
Fiber-optic Cable market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More
Gas Separation Membranes market is segmented by Type and by Application. Players, stakeholders, a ... Read More